IGFR1 and PI3KCA have been identified as target genes of FOXO3a in a colon carcinoma cell line [115], which indicates that FOXO3a may activate PI3K–PKB signaling pathway by multiple mechanisms and it could contribute to drug resistance in colon cancer. The gene discussed is FOXO3; the disease is colon carcinoma.